Clinical trial
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms. International, Multicenter Post-marketing Observational Study.
NCT01078545 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms. International, Multicenter Post-marketing Observational Study.
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- November 30, 2010
- Enrollment
- 729 (actual)
- Sites
- 143
Conditions
As the registry lists them; a condition with its own page is linked.
advanced prostate cancer, lower urinary tract symptoms